Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am Heart J
1 Am J Cardiol
1 Am J Emerg Med
1 Cardiovasc Res
3 Circ Arrhythm Electrophysiol
2 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
3 Circ Res
1 Circulation
2 Eur Heart J
3 Heart
2 Int J Cardiol
2 J Cardiol
8 J Cardiovasc Electrophysiol
1 J Interv Card Electrophysiol
1 Pacing Clin Electrophysiol
1 Resuscitation
1 Stroke

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. FREYER L, von Stulpnagel L, Spielbichler P, Sappler N, et al
    Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based Bavarian Alternative Detection of Atrial Fibrillation (eBRAVE-AF) trial.
    Am Heart J. 2021 Jul 9. pii: S0002-8703(21)00164.
    PubMed         Abstract available

    Am J Cardiol

  2. WEIDNER K, von Zworowsky M, Schupp T, Hoppner J, et al
    Effect of Anemia on the Prognosis of Patients with Ventricular Tachyarrhythmias.
    Am J Cardiol. 2021 Jul 8. pii: S0002-9149(21)00524.
    PubMed         Abstract available

    Am J Emerg Med

  3. PANTAZOPOULOS I, Boutsikos I, Mavrovounis G, Graikou T, et al
    Stress hormones kinetics in ventricular fibrillation cardiac arrest and resuscitation: Translational and therapeutic implications.
    Am J Emerg Med. 2021;50:14-21.
    PubMed         Abstract available

    Cardiovasc Res

  4. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2021 Jul 13. pii: 6319837. doi: 10.1093.

    Circ Arrhythm Electrophysiol

  5. ZEDDA A, Huo Y, Kronborg M, Ulbrich S, et al
    Left Atrial Isolation and Appendage Occlusion in Patients with Atrial Fibrillation at End Stage Left Atrial Fibrotic Disease.
    Circ Arrhythm Electrophysiol. 2021 Jul 16. doi: 10.1161/CIRCEP.121.010011.
    PubMed         Abstract available

  6. LEBLANC FJA, Vahdati Hassani F, Liesinger L, Qi X, et al
    Transcriptomic Profiling of Canine Atrial Fibrillation Models after One Week of Sustained Arrhythmia.
    Circ Arrhythm Electrophysiol. 2021 Jul 16. doi: 10.1161/CIRCEP.121.009887.
    PubMed         Abstract available

  7. PICCINI JP, Dufton C, Carroll IA, Healey JS, et al
    Bucindolol Decreases Atrial Fibrillation Burden in Patients with Heart Failure and the ADRB1 Arg389Arg Genotype.
    Circ Arrhythm Electrophysiol. 2021 Jul 16. doi: 10.1161/CIRCEP.120.009591.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  8. ANTHONY C, Griffin BP
    Vicious Cycle of Concurrent Low-Flow, Low-Gradient Aortic Stenosis and Atrial Fibrillation.
    Circ Cardiovasc Imaging. 2021 Jul 12:CIRCIMAGING121013061.

  9. ALSIDAWI S, Khan S, Pislaru SV, Thaden JJ, et al
    High Prevalence of Severe Aortic Stenosis in Low-Flow State Associated With Atrial Fibrillation.
    Circ Cardiovasc Imaging. 2021 Jul 12:CIRCIMAGING120012453.
    PubMed         Abstract available

    Circ Cardiovasc Interv

  10. MESNIER J, Cruz-Gonzalez I, Peral V, Nombela-Franco L, et al
    Ten-Year Outcomes Following Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Absolute or Relative Contraindications to Chronic Anticoagulation.
    Circ Cardiovasc Interv. 2021 Jul 16:CIRCINTERVENTIONS121010821.

    Circ Res

  11. HUTCHINGS DC, Pearman CM, Madders GW, Woods LS, et al
    PDE5 Inhibition Suppresses Ventricular Arrhythmias by Reducing SR Ca(2+) Content.
    Circ Res. 2021 Jul 12. doi: 10.1161/CIRCRESAHA.121.318473.
    PubMed         Abstract available

    Learning for Prevention of Sudden Cardiac Death.
    Circ Res. 2021;128:185-187.

  13. BENITAH JP, Gomez AM
    Is the Debate on the Flecainide Action on the RYR2 in CPVT Closed?
    Circ Res. 2021;128:332-334.


  14. FELKER GM, Butler J, Ibrahim NE, Pina IL, et al
    Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
    Circulation. 2021;144:180-182.

    Eur Heart J

  15. Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
    Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.

  16. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed         Abstract available


  17. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    PubMed         Abstract available

  18. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed         Abstract available

  19. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.

    Int J Cardiol

  20. SEN J, Tonkin A, Varigos J, Fonguh S, et al
    Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
    Int J Cardiol. 2021;337:9-15.
    PubMed         Abstract available

  21. NJI MAM, Solomon SD, Chen LY, Shah AM, et al
    Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
    Int J Cardiol. 2021 Jul 8. pii: S0167-5273(21)01100.
    PubMed         Abstract available

    J Cardiol

  22. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed         Abstract available

  23. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    PubMed         Abstract available

    J Cardiovasc Electrophysiol

  24. VERGARA P, Pignalberi C, Pisano EC, Maglia G, et al
    Circadian periodicity affects The Type of ventricular arrhythmias and efficacy of Implantable defibrillator therapies.
    J Cardiovasc Electrophysiol. 2021 Jul 12. doi: 10.1111/jce.15154.
    PubMed         Abstract available

  25. NAKAMURA K, Sasaki T, Minami K, Take Y, et al
    Prevalence, characteristics, and predictors of endocardial and nonendocardial conduction gaps during local impedance-guided extensive pulmonary vein isolation of atrial fibrillation with high-resolution mapping.
    J Cardiovasc Electrophysiol. 2021 Jul 13. doi: 10.1111/jce.15152.
    PubMed         Abstract available

  26. CLARKE JD, Piccini JP, Friedman DJ
    The Role of Posterior Wall Isolation in Catheter Ablation of Persistent Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2021 Jul 13. doi: 10.1111/jce.15164.
    PubMed         Abstract available

    Implantable cardioverter defibrillator shocks from ventricular tachyarrhythmias in patients with ischemic heart disease: preventative measures, shortcomings, cost-effectiveness and global practice perspectives.
    J Cardiovasc Electrophysiol. 2021 Jul 13. doi: 10.1111/jce.15161.
    PubMed         Abstract available

  28. DELLA ROCCA DG, Magnocavallo M, Natale VN, Gianni C, et al
    Clinical Presentation, Diagnosis, and Treatment of Atrioesophageal Fistula Resulting from Atrial Fibrillation Ablation.
    J Cardiovasc Electrophysiol. 2021 Jul 14. doi: 10.1111/jce.15168.
    PubMed         Abstract available

  29. BAYKANER T, Fazal M, Patel S, Zaman J, et al
    Is There Rule to the Chaos: Defining Stable Patterns in Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2021 Jul 14. doi: 10.1111/jce.15169.

  30. POPE MT, Kuklik P, Gala ABE, Leo M, et al
    Spatial and Temporal Variability of Rotational, Focal and Irregular Activity: Practical Implications for Mapping of Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2021 Jul 14. doi: 10.1111/jce.15170.
    PubMed         Abstract available

  31. SAHA S, Perschbacher D, Jones P, Frost K, et al
    A Novel Adaptive Insertable Cardiac Monitor Algorithm Improves the Detection of Atrial Fibrillation and Atrial Tachycardia in Silico.
    J Cardiovasc Electrophysiol. 2021 Jul 16. doi: 10.1111/jce.15178.
    PubMed         Abstract available

    J Interv Card Electrophysiol

  32. PONNUSAMY SS, Vijayaraman P
    Unmasking of left bundle branch potential in left bundle branch block during physiological pacing.
    J Interv Card Electrophysiol. 2021 Jul 10. pii: 10.1007/s10840-021-01028.

    Pacing Clin Electrophysiol

  33. ANTOLIC B, Kajdic N, Vrbajnscak M, Jan M, et al
    Integrated 3D intracardiac ultrasound imaging with detailed pulmonary vein delineation guided fluoroless ablation of atrial fibrillation.
    Pacing Clin Electrophysiol. 2021 Jul 10. doi: 10.1111/pace.14315.
    PubMed         Abstract available


  34. HARTVIG THOMSEN J, Hassager C, Erlinge D, Nielsen N, et al
    Repolarization and ventricular arrhythmia during targeted temperature management post cardiac arrest.
    Resuscitation. 2021 Jul 13. pii: S0300-9572(21)00252.
    PubMed         Abstract available


  35. GRIMALDI-BENSOUDA L, Le Heuzey JY, Ferrieres J, Leys D, et al
    Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors.
    Stroke. 2021 Jul 13:STROKEAHA120032704. doi: 10.1161/STROKEAHA.120.032704.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.